Design, synthesis, and evaluation of resveratrol derivatives as Aß1–42 aggregation inhibitors, antioxidants, and neuroprotective agents

C Lu, Y Guo, J Li, M Yao, Q Liao, Z Xie, X Li - Bioorganic & medicinal …, 2012 - Elsevier
A series of novel resveratrol derivatives were designed, synthesised and evaluated as
potential therapeutic agents for the treatment of Alzheimer's disease. Among these …
被引用次数：54 相关文章

Design, synthesis, and evaluation of resveratrol derivatives as Aß (₁-₄₂) aggregation inhibitors, antioxidants, and neuroprotective agents

C Lu, Y Guo, J Li, M Yao, Q Liao, Z Xie… - Bioorganic & Medicinal …, 2012 - hero.epa.gov
A series of novel resveratrol derivatives were designed, synthesised and evaluated as
potential therapeutic agents for the treatment of Alzheimer's disease. Among these …

[引用][C] Design, synthesis, and evaluation of resveratrol derivatives as A beta (1-42) aggregation inhibitors, antioxidants, and neuroprotective agents

C Lu, Y Guo, J Li, M Yao, Q Liao, Z Xie… - Bioorganic & Medicinal …, 2012 - scholarmate.com
A series of novel resveratrol derivatives were designed, synthesised and evaluated as
potential therapeutic agents for the treatment of Alzheimer's disease. Among these …

[引用][C] Design, synthesis, and evaluation of resveratrol derivatives as Aß1–42 aggregation inhibitors, antioxidants, and neuroprotective agents

C Lu, Y Guo, J Li, M Yao, Q Liao, Z Xie… - Bioorganic & Medicinal …, 2012 - cir.nii.ac.jp
Design, synthesis, and evaluation of resveratrol derivatives as Aß1–42 aggregation inhibitors,
antioxidants, and neuroprotective agents | CiNii Research CiNii 国立情報学研究所 学術情報 …

Design, synthesis, and evaluation of resveratrol derivatives as Aß (₁-₄₂) aggregation inhibitors, antioxidants, and neuroprotective agents.

C Lu, Y Guo, J Li, M Yao, Q Liao, Z Xie… - Bioorganic & Medicinal …, 2012 - europepmc.org
A series of novel resveratrol derivatives were designed, synthesised and evaluated as
potential therapeutic agents for the treatment of Alzheimer's disease. Among these …

Design, synthesis, and evaluation of resveratrol derivatives as Aß1–42 aggregation inhibitors, antioxidants, and neuroprotective agents

C Lu, Y Guo, J Li, M Yao, Q Liao, Z Xie, X Li - Bioorganic & Medicinal …, 2012 - infona.pl
A series of novel resveratrol derivatives were designed, synthesised and evaluated as
potential therapeutic agents for the treatment of Alzheimer's disease. Among these …

[引用][C] Design, synthesis, and evaluation of resveratrol derivatives as Aβ1―42 aggregation inhibitors, antioxidants, and neuroprotective agents

C LU, Y GUO, J LI, M YAO, Q LIAO… - Bioorganic & medicinal …, 2012 - pascal-francis.inist.fr
Design, synthesis, and evaluation of resveratrol derivatives as Aβ1―42 aggregation
inhibitors, antioxidants, and neuroprotective agents CNRS Inist Pascal-Francis CNRS …

Design, synthesis, and evaluation of resveratrol derivatives as Aß (₁-₄₂) aggregation inhibitors, antioxidants, and neuroprotective agents

C Lu, Y Guo, J Li, M Yao, Q Liao… - … & medicinal chemistry …, 2012 - pubmed.ncbi.nlm.nih.gov
A series of novel resveratrol derivatives were designed, synthesised and evaluated as
potential therapeutic agents for the treatment of Alzheimer's disease. Among these …

[引用][C] Design, synthesis, and evaluation of resveratrol derivatives as A beta (1-42) aggregation inhibitors, antioxidants, and neuroprotective agents

C Lu, Y Guo, J Li, M Yao, Q Liao, Z Xie… - Bioorganic & Medicinal …, 2012 - scholarmate.com
A series of novel resveratrol derivatives were designed, synthesised and evaluated as
potential therapeutic agents for the treatment of Alzheimer's disease. Among these …